Technology Platform - Available via Partnerships

Our patented thermotherapy platform includes innovative mobile laser devices, temperature monitoring devices, and sterile disposables, and is commercialized as regulatory-approved products through strategic partners in the U.S. and Europe, with a vision to do so on a global scale.

The Power of our Technology

Laser ablation is an effective way to destruct benign and malignant tumors and other pathological tissue in a minimally invasive setting. The CLS  product portfolio is based on patented technology and designed to deliver laser energy to heat the target tissue with high precision. During a treatment session, tissue temperature and necrosis of the target tissue, can be controlled by the user with high accuracy, while saving surrounding healthy tissue.

Mobile Laser Unit
Introducer System
Laser Applicator
Temperature Probe
Thermoguide™

The mobile laser unit is the laser source and controlling component of our systems.

  • Medical laser: wavelength 1064 nm.
  • Adjustable power allowing the user to optimize tissue temperatures as needed for optimal treatment outcome.

Non-cooled laser applicators, and procedure specific Introducer systems designed to suit anatomical needs.

  • Unique fiber technology optimizes the heat distribution in the tissue providing sharp and precise ablation zones.
  • Portfolio of non-cooled laser applicators for various imaging systems and ablation sizes. 

Temperature monitoring devices and safety guards enabling the physician to follow the progression of the ablation in near real-time.

  • Tissue temperature probes – for MRI US fusion-guidance.
  • Thermoguide™ Workstation – thermometry software when MRI is used for image guidance.

Partner with CLS – Accelerating Innovation to Market

At CLS, we are an agile, focused organization dedicated to turning breakthrough product innovation and design to the clinic.

We concentrate our resources on our core strengths:

  • Product Innovation: State-of-the-art product platform
  • Intellectual Property Leadership: Strong, actively managed patent portfolio
  • Regulatory Expertise: Proven track record in navigating and accelerating market approvals across the US, EU (MDR), and RoW.
  • Clinical Development Excellence: Deep experience in clinical application and therapy integration.
  • Strategic Partnerships: Collaborating with proven commercialization leaders in targeted regions.

We seek partners who:

  • Have established customer access and sales networks in high-margin segments.
  • Can drive market adoption of novel therapy concepts.
  • Offer products or clinical services in adjacent therapy areas.
  • Bring experience and interest in co-developing innovative, value-added solutions for customers.

Product Specifications

CLS holds market approvals and serves as the legal manufacturer of our patented products. Welcome to download our Technical Data Sheet for product details!

Therapy Areas

Today, our products are used in minimal invasive laser ablation of pathological tissue in patients with various conditions, including neurosurgery and urology.

Potential Partnerships

We are continuously exploring new potential partnerships with the aim of expanding to new markets and clinical indications. Welcome to reach out for more information!

Welcome to Clinical Laserthermia Systems.

Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!


Please choose your country or region

Global
US